GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

• Last SEC data release: 2024-11-14
• Last 15 days FTD volume: $43.02 M
• Last 3 months FTD volume: $56.6 M
• Last year FTD volume: $56.6 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
AstraZeneca AZN	$65.36 M	$0.20 B	🇬🇧 UK
Pfizer PFE	$47.84 M	$0.38 B	🇺🇸 USA
Merck MRK	$12.06 M	$85.74 M	🇺🇸 USA
Novartis NVS	$89.33 M	$0.14 B	🇨🇭 Switzerland
Sanofi SNY	$11.2 M	$72.21 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	$17.26 M	$41.19 M	🇮🇱 Israel
Dynavax Technologies DVAX	$8.42 M	$32.41 M	🇺🇸 USA